Biodemography of Aging Research Unit, Social Science Research Institute, Duke University, Durham, North Carolina, USA.
Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.
J Am Geriatr Soc. 2021 Aug;69(8):2306-2315. doi: 10.1111/jgs.17215. Epub 2021 May 19.
The regions with highest and lowest Alzheimer's disease (AD) mortality across the United States at state/county levels were identified and their contribution to the differences in total mortality rates between these regions was evaluated. The disease, disease group, sex, race/ethnicity, and place-of-death-related inter-region differences that engender the disparity in mortality were quantitatively described. The hypothesis that inter-regional differences in filling out death certificates are a major contributor to differences in AD mortality was tested.
Retrospective evaluation of death certificate data.
The United States.
Deceased US residents, 1999-2018.
Region-specific age-adjusted mortality rates and group-specific rate decomposition.
The county clusters with the highest and lowest AD mortality rates were in Washington (WA) and New York (NY), respectively, with other notable high-mortality clusters on the border of Tennessee, Georgia, and Alabama as well as in North Dakota and South Dakota. These patterns were stable over the 1999-2018 period. AD had the highest contribution to total mortality difference between WA and NY (156%, higher in WA), in contrast circulatory diseases had a contribution of comparable magnitude (154%) but were higher in NY. Differences in cause-of-death certificate coding, either through coding of non-AD dementias, or other conditions accompanying a potential AD death could not account for differences in AD mortality between NY and WA.
Inter-regional differences in filling out death certificates were not a major contributor to variation in AD mortality between the regions with the highest and lowest rates. The respective mitigation of the effects of neural and circulatory diseases and several other high-impact conditions would not negate the disparity in mortality between NY and WA.
确定美国各州/县层面阿尔茨海默病(AD)死亡率最高和最低的地区,并评估其对这些地区总死亡率差异的贡献。定量描述了导致死亡率差异的疾病、疾病组、性别、种族/民族和死亡地点相关的区域间差异。测试了区域间填写死亡证明的差异是导致 AD 死亡率差异的主要原因的假设。
回顾性评估死亡证明数据。
美国。
1999 年至 2018 年期间死亡的美国居民。
特定区域的年龄调整死亡率和特定组的死亡率分解。
AD 死亡率最高和最低的县集群分别位于华盛顿(WA)和纽约(NY),田纳西州、佐治亚州和阿拉巴马州边境以及北达科他州和南达科他州也有其他明显的高死亡率集群。这些模式在 1999-2018 年期间保持稳定。AD 对 WA 和 NY 之间总死亡率差异的贡献最大(156%,WA 更高),而循环系统疾病的贡献相当(154%),但在 NY 更高。死亡证明编码方面的差异,无论是通过 AD 痴呆症的编码,还是其他伴随潜在 AD 死亡的疾病的编码,都不能解释 NY 和 WA 之间 AD 死亡率的差异。
填写死亡证明的区域间差异不是导致死亡率最高和最低地区之间 AD 死亡率差异的主要原因。减轻神经和循环系统疾病以及其他几种高影响疾病的影响,并不会消除 NY 和 WA 之间的死亡率差异。